117 related articles for article (PubMed ID: 38679999)
1. LncRNA ANRIL Promotes Glucose Metabolism and Proliferation of Colon Cancer in a High-Glucose Environment and is Associated with Worse Outcome in Diabetic Colon Cancer Patients.
Mosaad H; Shalaby SM; Mahmoud NM; Ahmed MM; Fayed A; Ashour HR; Sarhan W
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1371-1381. PubMed ID: 38679999
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ANRIL negatively regulated chitooligosaccharide-induced radiosensitivity in colon cancer cells by sponging miR-181a-5p.
Sun C; Shen C; Zhang Y; Hu C
Adv Clin Exp Med; 2021 Jan; 30(1):55-65. PubMed ID: 33529508
[TBL] [Abstract][Full Text] [Related]
3. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway.
Cheng B; Rong A; Zhou Q; Li W
J Exp Clin Cancer Res; 2020 Jan; 39(1):5. PubMed ID: 31900207
[TBL] [Abstract][Full Text] [Related]
4. Roles of DANCR/microRNA-518a-3p/MDMA ceRNA network in the growth and malignant behaviors of colon cancer cells.
Sun Y; Cao B; Zhou J
BMC Cancer; 2020 May; 20(1):434. PubMed ID: 32423468
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
[TBL] [Abstract][Full Text] [Related]
6. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1.
Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH
J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519
[TBL] [Abstract][Full Text] [Related]
7. NF-κB maintains the stemness of colon cancer cells by downregulating miR-195-5p/497-5p and upregulating MCM2.
Wang L; Guo J; Zhou J; Wang D; Kang X; Zhou L
J Exp Clin Cancer Res; 2020 Oct; 39(1):225. PubMed ID: 33109220
[TBL] [Abstract][Full Text] [Related]
8. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
Tan H; Zhao L
J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
10. Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells.
Ma W; Qiao J; Zhou J; Gu L; Deng D
Mol Cancer; 2020 Feb; 19(1):42. PubMed ID: 32106863
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA antisense noncoding RNA in the INK4 locus inhibition alleviates airway remodeling in asthma through the regulation of the microRNA-7-5p/early growth response factor 3 axis.
Wang L; Liu X
Immun Inflamm Dis; 2023 Apr; 11(4):e823. PubMed ID: 37102654
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
Yang C; Wu K; Wang S; Wei G
J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
[TBL] [Abstract][Full Text] [Related]
13. LncRNA ANRIL promotes HR repair through regulating PARP1 expression by sponging miR-7-5p in lung cancer.
Du Z; Zhang F; Liu L; Shen H; Liu T; Jin J; Yu N; Wan Z; Wang H; Hu X; Chen Y; Cai J
BMC Cancer; 2023 Feb; 23(1):130. PubMed ID: 36755223
[TBL] [Abstract][Full Text] [Related]
14. LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
Zhang D; Zhang Y; Sun X
Asia Pac J Clin Oncol; 2021 Jun; 17(3):253-263. PubMed ID: 33078907
[TBL] [Abstract][Full Text] [Related]
15. The linear ANRIL transcript P14AS regulates the NF-κB signaling to promote colon cancer progression.
Ma W; Hu J
Mol Med; 2023 Dec; 29(1):162. PubMed ID: 38041015
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA ANRIL Promotes Cervical Cancer Development by Acting as a Sponge of miR-186.
Zhang JJ; Wang DD; Du CX; Wang Y
Oncol Res; 2018 Apr; 26(3):345-352. PubMed ID: 28550682
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
Hu X; Jiang H; Jiang X
Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ANRIL up-regulates CCND1 via sponging miR-98-5p to promote TGF-β1-induced human airway smooth muscle cell proliferation, migration, and extracellular matrix deposition.
Zhong ZG; Dong CP; Guo XH; Chen J; Zhu LP; Zhang M
Kaohsiung J Med Sci; 2022 Jul; 38(7):633-642. PubMed ID: 35396910
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.
Yin Y; Yang W; Zhang L; Liu K; Luo Z
Hematology; 2021 Dec; 26(1):160-169. PubMed ID: 33528317
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
